Literature DB >> 17459636

[Simultaneous outbreaks of rotavirus and respiratory syncytial virus in Paris: a 12-year survey].

J-B Armengaud1, M J El Hajje, F Moulin, E Marc, M Chalumeau, P Lebon, D Gendrel.   

Abstract

OBJECTIVE: The authors had for aim to study the coincidence of RSV and rotavirus epidemic peaks in pediatric patients hospitalized in the Paris area.
METHODOLOGY: A retrospective hospital-based monocentric cohort study was made over a 12-year period (1993-2004). Clinical and laboratory findings were prospectively collected on admission.
RESULTS: Three thousand and four hundred ninety-six stool samples were positive for rotavirus; 3,507 nasopharyngeal aspirates were positive for RSV. The coincidence of epidemic peaks for both viruses in November, December, and January was observed during the 12 years of the study.
CONCLUSION: The exact coincidence of winter outbreaks of RSV and rotavirus is a characteristic of the Paris area. It contributes to increase overcrowding in pediatric units and nosocomial infections.

Entities:  

Mesh:

Year:  2007        PMID: 17459636     DOI: 10.1016/j.medmal.2007.02.005

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  6 in total

Review 1.  [Epidemiology of infectious acute diarrhoea in France and Europe].

Authors:  S Alain; F Denis
Journal:  Arch Pediatr       Date:  2007-10       Impact factor: 1.180

Review 2.  Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

Review 3.  Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review.

Authors:  Isla Ogilvie; Hanane Khoury; Mireille M Goetghebeur; Antoine C El Khoury; Carlo Giaquinto
Journal:  BMC Infect Dis       Date:  2012-03-19       Impact factor: 3.090

Review 4.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-05       Impact factor: 4.558

5.  Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.

Authors:  Susanne Hartwig; Matti Uhari; Marjo Renko; Perrine Bertet; Maria Hemming; Timo Vesikari
Journal:  BMC Health Serv Res       Date:  2014-12-11       Impact factor: 2.655

6.  Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.

Authors:  Edouard Ledent; Hugo Arlegui; Hubert Buyse; Peter Basile; Naveen Karkada; Nicolas Praet; Gaëlle Nachbaur
Journal:  BioDrugs       Date:  2018-04       Impact factor: 5.807

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.